Present the current status of gene therapy for retinal diseases Research Paper

Present the current attitude of agent therapy for retinal diseases - Research Paper ExampleDiseases of the eye which have the potential of being treatable with cistron therapy in future are retinitis pigmentosa, proliferative retinopathy, autoimmune uveitis, gyrate atrophy, age-related macular degeneration, retinoblastoma and Lebers congential amaurosis. Thus gene therapy has the potential to treat various inheriting retinal diseases in future. As of now, no product has been approved for clinical use and most of them are in clinical trial stage. Introduction Whenever a particular gene is defective or absent, on that point is either absence of a particular protein, or there is production of deviate protein or the summate of protein produced is insufficient. This causes diseased states. Many of these diseases can be either blocked or treated by replacing the abnormal gene, or by introducing the absent gene or by supplementing the defective gene. Using genes thus to prevent or treat a disease is known as gene therapy (HGPI, 2009). This is an experimental technique and is make by inserting contractable significant into the patients cells. The genes thus introduced exert their benefits by either compensating for the abnormal genes or by producing beneficial protein or by supplementing the abnormal gene (Hecht, 2004). ... g genetic material into cells that cause crabby person cells to revert back to normal cells, delivering genes of bacteria or virus as a form of vaccination, elivering genetic material that either impedes or promotes growth of a new tissue and delivering genetic material that stimulates healing of a damaged tissue (Hecht, 2004). Currently, research is going on for gene therapy by various approaches in different parts of the world for various diseases like combined immuno-deficiencies, hemophilia, Parkinsons disease, cancer and even HIV. Thus, gene therapy has emerged as unrivalled of the novel treatment strategies for several untreatab le diseases (Singh and Tripathi, 2002). One significant bailiwick in which enormous research has been done with regard to gene therapy is retinal diseases. In this article, the current status of gene therapy for retinal diseases will be discussed through review of suitable literature. Why is retina suitable for gene therapy? Several genes which are responsible for various inherited retinal disorders have been identified (Dejneka and Bennett, 2001). Eye, especially retina, is one of the best suitable targets for gene therapy because of easy accessibility and allowance for local application of various therapeutical agents, along with decreased risk for systemic effects. Another major advantage is that the effects of therapy can be monitored through various non-invasive tests. Of the parts in the ocular system, retina is the most suitable candidate for gene therapy. This is because the gist of virus that needs to be injected into the retina is just 1/1000 of that needed for other sy stemic diseases (Singh and Tripathi, 2002). The line of reasoning ocular roadblock that is present in the eye separates eye from other parts of the body and protects retina. This barrier